Plenary Session - From Bench to Bedside and Back: the development and FDA approval of vemurafenib for melanoma patients

10/06/2026 17:30 18:15

Room P1+2+3

Time	Session

17:30 17:40	Title to be announced Darrin Stuart Speaker Switzerland
17:40 17:50	Learnings from RAF inhibitor drug discovery Gideon Bollag Speaker USA
17:50 18:00	Title to be announced KeithFlaherty Speaker USA
18:00 18:15	Discussion